IDEX is benefiting from strong orders, record Health & Science Technologies sales and exposure to data centers and semiconductors. The stock is rated Buy despite a premium valuation, supported by improving guidance and durable cash generation.
IDEX Corporation (IEX) merits a Buy rating for moderate-risk investors with a medium-term horizon. The company combines specialized industrial products, strong cash generation, improving orders and exposure to data centers, semiconductors, water, aerospace and defense.
The central growth engine is Health & Science Technologies, where Q3 2026 sales reached a record level and Q2 organic orders rose 47%. IDEX also raised full-year 2026 organic growth guidance to 6.5% to 6.8% and adjusted EPS guidance to $8.91 to $8.96 after reporting Q3 adjusted EPS of $2.33.
The trade-off is valuation. IEX carries a trailing P/E of 33.6x, a forward P/E of 24.6x and a PEG ratio of 1.8x. That is not a bargain multiple, but the premium has support from a 7-for-7 earnings beat record, a 4.3% free-cash-flow yield, strong margins and improving visibility into 2027.
IDEX Corporation (IEX) is a Northbrook, Illinois-based industrial technology company founded in 1987 and listed on the NYSE. It employs approximately 8,700 people and serves customers across the United States, North America, Europe, Asia and other international markets.
The company operates through Health & Science Technologies, Fluid & Metering Technologies, and Fire & Safety/Diversified Products. Its products include precision pumps, fluidics, filtration systems, valves, seals, optical components, firefighting equipment, rescue tools, dispensing systems and engineered clamping products.
IDEX sells components that are often small portions of a customer's total equipment cost but carry high operating importance. The 2025 Form 10-K reported that no customer represented more than 3% of sales. That customer spread gives IEX a sturdier revenue base than a supplier dependent on one large account.
Health & Science Technologies is the largest segment, contributing $1.5B, or 43.2% of 2025 revenue. Fluid & Metering Technologies contributed $1.2B, or 35.3%, while Fire & Safety/Diversified Products contributed $745M, or 21.5%.
HST delivered the strongest Q2 2026 performance, with $415.0M of sales, 12% organic growth and a 28.7% adjusted EBITDA margin. Q3 results continued the broader momentum, with management citing advantaged markets and larger acquired businesses as important contributors.
FMT generated $317.1M of Q2 sales and 1% organic growth. Municipal water, semiconductor and mining demand offset weakness in energy, agriculture and chemicals. FSDP generated $189.9M of Q2 sales, down 1% organically, as BAND-IT aerospace strength partly offset weaker European rescue and dispensing activity.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
IDEX does not rely on one flagship product. Its flagship model is a portfolio of mission-critical components and systems, including positive-displacement pumps, high-purity filtration, precision seals, thermal-management parts, optical components and firefighting pumps.
Performance Pneumatics supplies primary and standby power-generation applications tied to data-center construction, along with liquid-cooling flow-control solutions. In semiconductors, IEX supplies high-purity gas filtration, sealing, optical detection and thermal-management components for process tools, inspection systems and metrology equipment.
IDEX Intelligent Water provides analytics for municipal wastewater management. FMT also supplies ultra-high-purity pumps, heaters and fluid-management solutions for semiconductor fabrication facilities. These products sit close to customer processes where reliability and specification compliance matter more than a small difference in purchase price.
IEX's competitive advantage comes from engineering depth, qualification requirements and a decentralized portfolio of niche businesses. The 2025 Form 10-K identifies product quality, design and engineering, customer-specification compliance, delivery, service and distribution as core competitive factors.
The company is directing innovation toward higher-growth applications. Data center, semiconductor, and space and defense applications represented more than one-third of HST revenue year to date in Q2 2026. Mott's filtration business also lifted recurring revenue to approximately 50% of HST's semiconductor portfolio.
The 8020 operating framework adds a capital-allocation advantage. Management uses it to direct resources toward businesses with the strongest growth and return potential. The model is particularly valuable in a portfolio where small operating improvements across many niche businesses can produce a meaningful group-level margin effect.
IDEX operates manufacturing, sales, service and administrative facilities in more than 20 countries. Its broad footprint supports international customers while reducing dependence on one production site or one geographic market.
Management is investing in throughput, staffing, supply-chain readiness and selective capacity expansions. The 2026 capital-expenditure forecast increased to approximately $110M, up from $90M, with the additional spending directed toward high-growth and high-return businesses.
Q2 2026 free cash flow reached $177M, and management reported liquidity above $1.1B. The company also repurchased $77M of shares and paid $54M of dividends in the quarter. Planned quarterly repurchases of approximately $75M through the rest of 2026 provide an additional per-share earnings support.
IDEX participates in a collection of specialized industrial markets rather than one uniform market. External industry estimates place the global industrial machinery market between $717.5B in 2025 and $1.31T by 2031, with growth estimates ranging from 5.1% to 8.4% depending on the scope.
The most relevant demand drivers for IEX are automation, factory investment, reshoring, water infrastructure, semiconductor capacity, data-center construction and aerospace programs. These markets reward suppliers that can meet strict technical requirements and deliver reliably.
The latest operating evidence supports a healthier demand cycle. Q3 2026 orders reached $991.2M, up 13%, while Q2 orders exceeded $1.0B and grew 28% organically. Management also described improving short-cycle activity in FMT and FSDP after stronger direct OEM and longer-cycle demand appeared first.
Like what you're reading?
Get full access to AI-powered research reports, market analysis, and portfolio tools.
IDEX serves original-equipment manufacturers, industrial distributors, municipalities, laboratory-equipment producers, semiconductor-equipment companies, aerospace customers, fire departments and defense-related applications. The customer base spans industrial, life sciences, energy, water, fire suppression and semiconductor markets.
The 2025 sales mix included industrial at 15%, life sciences at 15%, energy at 11%, fire suppression at 9%, water at 9% and semiconductor at 7%. No customer accounted for more than 3% of revenue, which limits the damage from the loss of any individual account.
Customer behavior is becoming more favorable in HST. Management said customers are placing orders with request dates farther into the future, primarily to reserve capacity. A large data-center pneumatics order received in Q2 was positioned for 2027, giving IEX longer visibility than its traditional short-cycle businesses.
IDEX competes with different companies across its three segments. Dover (DOV) overlaps in pumps and process solutions. Parker Hannifin (PH) competes in fluid handling, filtration, pneumatics and engineered materials. Graco (GGG) overlaps in dispensing and fluid-management equipment, while Watts Water Technologies (WTS) competes in water and flow-control applications.
The 2025 Form 10-K states that no single competitor offers all of IDEX's products or serves all of its markets. That fragmented structure is important. IEX can defend individual niches through engineering and customer qualification without having to dominate the entire industrial machinery sector.
Relative to broader industrial companies, IEX offers a more focused mix of specialized components and applied technologies. Its advantage is strongest where a product represents a small portion of a customer's bill of materials but a large portion of the customer's operating risk.
The macro picture is mixed. Management cited higher inflation, interest-rate direction and geopolitical conditions as factors affecting industrial customers. FMT still faced softer demand in chemicals, energy and agriculture during Q2, while European rescue demand pressured FSDP.
Trade policy has had a direct financial effect. IEX reported that IEEPA-related tariff impacts reduced Q2 sales by $14.7M, while refunds, interest and customer rebates produced a net adjusted EPS benefit of $0.08. The refund helped Q2 margins, but it should not be treated as a recurring operating gain.
Secular demand is more constructive than the broad industrial cycle. Data-center construction, semiconductor equipment, municipal water, aerospace and defense are producing strong orders even while portions of traditional industrial demand remain subdued. That mix shift gives IEX a useful buffer against a single macro slowdown.
IDEX earns an A- on balance sheet health thanks to strong cash generation, a 4.3% free-cash-flow yield and a diversified customer base with no account above 3% of sales.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Q3 adjusted EPS reached $2.33 as IDEX lifted full-year 2026 adjusted EPS guidance to $8.91-$8.96 and organic growth guidance to 6.5%-6.8%.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Management’s raised outlook is backed by 28% organic order growth in the quarter and a 47% jump in Q2 organic orders at Health & Science Technologies.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →IDEX trades at 33.6x trailing earnings and 24.6x forward earnings, a premium multiple tempered by a 7-for-7 earnings beat record and improving 2027 visibility.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →At $260 fair value, IDEX sits between the report’s Buy and Sell thresholds, with the premium justified by margin strength, recurring revenue and high-growth end markets.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →IDEX Corporation (IEX) is becoming a higher-quality growth industrial. The portfolio is shifting toward data centers, semiconductors, space and defense, water and other applications where engineered components carry high customer value.
The financial foundation is solid: $616.8M of 2025 free cash flow, a 2.86 current ratio, 0.46 debt-to-equity and strong quarterly cash generation. The main investment risk is valuation, not business fragility.
The medium-term setup favors disciplined accumulation rather than chasing momentum. IEX has the order growth, margin profile and balance-sheet flexibility to compound value, but the Buy case works best when entry price respects the premium already embedded in the stock.
Get AI-powered research reports, daily market intelligence, and a personal analyst in your pocket.
Get Full Access →Not ready to subscribe? ·
Cancel anytime
IDEX Corporation (IEX) slips 0.2% even after posting earnings beats, as investors weigh the latest results against broader market sentiment and outlook.
Old Dominion Freight Line, Inc. (ODFL) drops after reporting third-quarter results that beat estimates on both earnings and revenue. Even with strong year-over-year growth, investors sold the stock as the market reset expectations for freight volumes and future upside.
Banco Santander, S.A. (SAN) drops after Q3 2026 earnings as investors focus on Brazil weakness, rising loan-loss provisions, and a 2% decline in attributable profit. The bank beat EPS estimates and lifted underlying profit, but the market is weighing earnings quality and dividend timing over the headline beat.